Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT), http://www.pvct.com, a development-stage oncology and dermatology biopharmaceutical company, announced that it has appointed Dr. Joseph M. Chalil, MD, MBA, FACHE, to its Strategic Advisory Board.
Dr. Chalil is Associate Director, Health Science Executives of Boehringer Ingelheim, the world’s largest privately held pharmaceutical company. Headquartered in Ingelheim, Germany, the company operates globally in more than 50 countries. In 2012, Boehringer Ingelheim achieved net sales of 19.1 billion (USD); R&D expenditure in the business area of prescription medicines reached a quarter of its net sales.
Help employers find you! Check out all the jobs and post your resume.
